Amarin Corp Plc (AMRN)

[dukesking]

RMB, here’s a link to their latest press release. John Climax has no problem talking about Epeleuton and all of its’s potential for treating Covid, NASH, CVD, lipid disorder, metabolic diseases and diabetes. They must have tons of funding to be able to do all the research and trials they’re doing. I’ve questioned IR about Afimmune/Epeleuton and wether their patents protect against the REDUCE-IT and Marine indications. It’s the only email they haven’t responded to of my last 5. Epeleuton is a new chemical entity and I view them as a potential threat to AMRN. AMRN may have patents that protect against this threat and Affimune may be restricted by supply like generics. They are a few years away from a CVD label and further trial results are due out Q3 2022 for treating high trigs. The news is great with regards to Vascepa and Covid but at this point it’s a double edged sword to me.

https://www.afimmune.com/2021/08/26/afimmunes-epeleuton-shows-large-decreases-in-viral-load-and-pathological-changes-in-covid-19-study/